Thomas Touboul1, Shujuan Chen2, Cuong C To1, Sergio Mora-Castilla1, Karen Sabatini1, Robert H Tukey2, Louise C Laurent3. 1. Department of Reproductive Medicine, UC San Diego, La Jolla, CA 92037, United States. 2. Department of Chemistry & Biochemistry, UC San Diego, La Jolla, CA 92093, United States; Department of Pharmacology, UC San Diego, La Jolla, CA 92093, United States. 3. Department of Reproductive Medicine, UC San Diego, La Jolla, CA 92037, United States. Electronic address: llaurent@ucsd.edu.
Abstract
BACKGROUND & AIMS: Hepatocytes differentiated from human embryonic stem cells (hESCs) have the potential to overcome the shortage of primary hepatocytes for clinical use and drug development. Many strategies for this process have been reported, but the functionality of the resulting cells is incomplete. We hypothesize that the functionality of hPSC-derived hepatocytes might be improved by making the differentiation method more similar to normal in vivo hepatic development. METHODS: We tested combinations of growth factors and small molecules targeting candidate signaling pathways culled from the literature to identify optimal conditions for differentiation of hESCs to hepatocytes, using qRT-PCR for stage-specific markers to identify the best conditions. Immunocytochemistry was then used to validate the selected conditions. Finally, induction of expression of metabolic enzymes in terminally differentiated cells was used to assess the functionality of the hESC-derived hepatocytes. RESULTS: Optimal differentiation of hESCs was attained using a 5-stage protocol. After initial induction of definitive endoderm (stage 1), we showed that inhibition of the WNT/β-catenin pathway during the 2nd and 3rd stages of differentiation was required to specify first posterior foregut, and then hepatic gut cells. In contrast, during the 4th stage of differentiation, we found that activation of the WNT/β-catenin pathway allowed generation of proliferative bipotent hepatoblasts, which then were efficiently differentiated into hepatocytes in the 5th stage by dual inhibition of TGF-β and NOTCH signaling. CONCLUSION: Here, we show that stage-specific regulation of the WNT/β-catenin pathway results in improved differentiation of hESCs to functional hepatocytes.
BACKGROUND & AIMS: Hepatocytes differentiated from human embryonic stem cells (hESCs) have the potential to overcome the shortage of primary hepatocytes for clinical use and drug development. Many strategies for this process have been reported, but the functionality of the resulting cells is incomplete. We hypothesize that the functionality of hPSC-derived hepatocytes might be improved by making the differentiation method more similar to normal in vivo hepatic development. METHODS: We tested combinations of growth factors and small molecules targeting candidate signaling pathways culled from the literature to identify optimal conditions for differentiation of hESCs to hepatocytes, using qRT-PCR for stage-specific markers to identify the best conditions. Immunocytochemistry was then used to validate the selected conditions. Finally, induction of expression of metabolic enzymes in terminally differentiated cells was used to assess the functionality of the hESC-derived hepatocytes. RESULTS: Optimal differentiation of hESCs was attained using a 5-stage protocol. After initial induction of definitive endoderm (stage 1), we showed that inhibition of the WNT/β-catenin pathway during the 2nd and 3rd stages of differentiation was required to specify first posterior foregut, and then hepatic gut cells. In contrast, during the 4th stage of differentiation, we found that activation of the WNT/β-catenin pathway allowed generation of proliferative bipotent hepatoblasts, which then were efficiently differentiated into hepatocytes in the 5th stage by dual inhibition of TGF-β and NOTCH signaling. CONCLUSION: Here, we show that stage-specific regulation of the WNT/β-catenin pathway results in improved differentiation of hESCs to functional hepatocytes.
Authors: Karim Si-Tayeb; Fallon K Noto; Masato Nagaoka; Jixuan Li; Michele A Battle; Christine Duris; Paula E North; Stephen Dalton; Stephen A Duncan Journal: Hepatology Date: 2010-01 Impact factor: 17.425
Authors: J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones Journal: Science Date: 1998-11-06 Impact factor: 47.728
Authors: Meritxell Huch; Helmuth Gehart; Ruben van Boxtel; Karien Hamer; Francis Blokzijl; Monique M A Verstegen; Ewa Ellis; Martien van Wenum; Sabine A Fuchs; Joep de Ligt; Marc van de Wetering; Nobuo Sasaki; Susanne J Boers; Hans Kemperman; Jeroen de Jonge; Jan N M Ijzermans; Edward E S Nieuwenhuis; Ruurdtje Hoekstra; Stephen Strom; Robert R G Vries; Luc J W van der Laan; Edwin Cuppen; Hans Clevers Journal: Cell Date: 2014-12-18 Impact factor: 41.582
Authors: Samantha A Morris; Patrick Cahan; Hu Li; Anna M Zhao; Adrianna K San Roman; Ramesh A Shivdasani; James J Collins; George Q Daley Journal: Cell Date: 2014-08-14 Impact factor: 41.582
Authors: Robert P Fordham; Shiro Yui; Nicholas R F Hannan; Christoffer Soendergaard; Alison Madgwick; Pawel J Schweiger; Ole H Nielsen; Ludovic Vallier; Roger A Pedersen; Tetsuya Nakamura; Mamoru Watanabe; Kim B Jensen Journal: Cell Stem Cell Date: 2013-10-17 Impact factor: 24.633
Authors: Yu Wang; Sharmin Alhaque; Kate Cameron; Jose Meseguer-Ripolles; Baltasar Lucendo-Villarin; Hassan Rashidi; David C Hay Journal: J Vis Exp Date: 2017-03-02 Impact factor: 1.355
Authors: Cong Du; Yuan Feng; Dongbo Qiu; Yan Xu; Mao Pang; Nan Cai; Andy Peng Xiang; Qi Zhang Journal: Stem Cell Res Ther Date: 2018-03-09 Impact factor: 6.832